Management of women at high risk for breast cancer: New imaging beyond mammography

Breast

Volumn 14, Issue 6, 2005, Pages 480-486

  Kuhl, C K ^a   Kuhn, W ^a   Schild, H ^a  

^a UNIVERSITY OF BONN   (Germany)

Author keywords

Familial breast cancer; Hereditary breast cancer; Magnetic resonance imaging; Mammography; MRI; Prevention; Screening; Surveillance

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN;

ARTICLE; BREAST CANCER; CANCER INCIDENCE; CANCER RISK; CANCER SCREENING; DIAGNOSTIC ACCURACY; FAMILIAL CANCER; FAMILY HISTORY; FEMALE; GENE MUTATION; GENETIC RISK; HEREDITY; HIGH RISK PATIENT; HUMAN; MAMMOGRAPHY; MASTECTOMY; MORBIDITY; MORTALITY; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; SECONDARY PREVENTION; SENSITIVITY AND SPECIFICITY;

EID: 28044462901     PISSN: 09609776     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.breast.2005.08.005     Document Type: Article

References (40)

1. Surveillance, Epidemiology and End Results (SEER) Program. SEER Cancer Statistics Review 1973-1995. Female Breast Cancer: Trends in SEER incidence and US mortality, National Cancer Institute. Available at: URL http://www-seer.ims.nci.nih.gov/Publications/CSR7395/breast.pdf.
2. H.T. Lynch W.A. Albano B.S. Danes M.A. Layton et al. Genetic pre-disposition to breast cancer Cancer 53 1984 612-622
3. Y. Miki J. Swensen D. Shattuck-Eidens P.A. Futreal et al. A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1 Science 266 1994 66-71
4. R. Wooster G. Bignell J. Lancaster S. Swift et al. Identification of the breast cancer susceptibility gene BRCA2 Nature 378 1995 789-792
5. C.I. Szabo M.C. King Population genetics of BRCA1 and BRCA2 Am J Hum Genet 60 1997 1013-1020
6. O. Serova S. Mazoyer N. Puget et al. Mutations in BRCA1 and BRCA2 in breast cancer families: Are there more breast cancer susceptibility genes? Am J Hum Genet 60 1997 486-495
7. D. Ford D.F. Easton D.T. Bishop S.A. Narod D.E. Goldgar Risks of cancer in BRCA1-mutation carriers. Breast cancer linkage consortium Lancet 343 1994 692-695
8. A. Antoniou P.D. Pharoah S. Narod et al. Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history: A combined analysis of 22 studies Am J Hum Genet 72 2003 1117-1130
9. J.E. Armes A.J. Egan M.C. Southey G.S. Dite M.R. McCredie G.G. Giles et al. The histologic phenotypes of breast carcinoma occurring before age 40 years in women with and without BRCA1 or BRCA2 germline mutations: A population-based study Cancer 83 1998 2335-2345
10. S.R. Lakhani J. Jacquemire J.P. Sloane B.A. Gusterson T.J. Anderson M.J. van de Vijver et al. Multifactorial analysis of differences between sporadic breast cancers and cancers involving BRCA1 and BRCA2 mutations J Natl Cancer Inst 90 1998 1138-1145
11. J.N. Marcus P. Watson D.L. Page et al. Hereditary breast cancer: pathobiology, prognosis, and BRCA1 and BRCA2 gene linkage Cancer 77 1996 697-709
12. Breast Cancer Linkage Consortium Pathology of familial breast cancer: differences between breast cancers in carriers of BRCA1 or BRCA2 mutations and sporadic cases Lancet 349 1997 1505-1510
13. H.F. Vasen N.E. Haites D.G. Evans et al. Current policies for surveillance and management in women at risk of breast and ovarian cancer: A survey among 16 European family cancer clinics. European familial breast cancer collaborative group Eur J Cancer 34 1998 1922-1926
14. W. Burke M. Daly J. Garber et al. Recommendations for follow-up care of individuals with an inherited predisposition to cancer. II. BRCA1 and BRCA2. Cancer genetics studies consortium JAMA 277 1997 997-1003 [Review]
15. K. Metcalfe H.T. Lynch P. Ghadirian et al. Contralateral breast cancer in BRCA1 and BRCA2 mutation carriers J Clin Oncol 22 2004 2328-2335
16. K.F. Hoskins J.E. Stopfer K.A. Calzone Assessment and counseling for women with a family history of breast cancer. A guide for clinicians JAMA 273 1995 577-585
17. K.A. Metcalfe V. Goel L. Lickley J. Semple S.A. Narod Prophylactic bilateral mastectomy: Patterns of practice Cancer 95 2002 236-242
18. L.C. Hartmann D.J. Schaid J.E. Woods et al. Efficacy of bilateral prophylactic mastectomy in women with a family history of breast cancer N Engl J Med 340 1999 77-84
19. H. Meijers-Heijboer B. van Geel W.L. van Putten et al. Breast cancer after prophylactic bilateral mastectomy in women with a BRCA1 or BRCA2 mutation N Engl J Med 345 2001 159-164
20. T.R. Rebbeck T. Friebel H.T. Lynch et al. Bilateral prophylactic mastectomy reduces breast cancer risk in BRCA1 and BRCA2 mutation carriers: The PROSE Study Group J Clin Oncol 22 2004 1055-1062
21. E.B. Claus J.M. Schildkraut W.D. Thompson N.J. Risch The genetic attributable risk of breast and ovarian cancer Cancer 77 1996 2318-2324
22. K. Kerlikowske D. Grady J. Barclay E.A. Sickles A. Eaton V. Ernster Positive predictive value of screening mammography by age and family history of breast cancer JAMA 270 1993 2444-2450
23. W.D. Foulkes K. Metcalfe W. Hanna et al. Disruption of the expected positive correlation between breast tumor size and lymph node status in BRCA1-related breast carcinoma Cancer 98 2003 1569-1577
24. Q. Zhong C.F. Chen P.L. Chen W.H. Lee BRCA1 facilitates microhomology-mediated end joining of DNA double strand breaks J Biol Chem 277 2002 28641-28647
25. K. Somasundaram Breast cancer gene 1 (BRCA1): Role in cell cycle regulation and DNA repair - perhaps through transcription J Cell Biochem 88 2003 1084-1091 [Review]
26. S.K. Sharan M. Morimatsu U. Albrecht D.S. Lim E. Regel C. Dinh et al. Embryonic lethality and radiation hypersensitivity mediated by Rad51 in mice lacking BRCA2 Nature 386 1997 804-810
27. M. Tilanus-Linthorst L. Verhoog I.M. Obdeijn et al. A BRCA1/2 mutation, high breast density and prominent pushing margins of a tumor independently contribute to a frequent false-negative mammography Int J Cancer 102 2002 91-95
28. C.K. Kuhl R.K. Schmutzler C.C. Leutner et al. Breast MR imaging screening in 192 women proved or suspected to be carriers of a breast cancer susceptibility gene: Preliminary results Radiology 215 2000 267-279
29. C.T. Brekelmans C. Seynaeve C.C. Bartels et al. Effectiveness of breast cancer surveillance in BRCA1/2 gene mutation carriers and women with high familial risk J Clin Oncol 19 2001 924-930
30. L. Scheuer N.D. Kauff M. Robson et al. Outcome of preventive surgery and screening for breast and ovarian cancer in BRCA mutation carriers J Clin Oncol 20 2002 1260-1268
31. G.P. Gui R.K. Hogben G. Walsh R. A'Hern R. Eeles The incidence of breast cancer from screening women according to predicted family history risk: does annual clinical examination add to mammography? Eur J Cancer 37 2001 1668-1673
32. I.K. Komenaka B.A. Ditkoff K.A. Joseph D. Russo P. Gorroochurn M. Ward et al. The development of interval breast malignancies in patients with BRCA mutations Cancer 100 2004 2079-2083
33. M.J. Stoutjesdijk C. Boetes G.J. Jager et al. Magnetic resonance imaging and mammography in women with a hereditary risk of breast cancer J Natl Cancer Inst 93 2001 1095-1102
34. E. Warner D.B. Plewes R.S. Shumak et al. Comparison of breast magnetic resonance imaging, mammography, and ultrasound for surveillance of women at high risk for hereditary breast cancer J Clin Oncol 19 2001 3524-3531
35. E. Warner D.B. Plewes K.A. Hill P.A. Causer J.T. Zubovits R.A. Jong et al. Surveillance of BRCA1 and BRCA2 mutation carriers with magnetic resonance imaging, ultrasound, mammography, and clinical breast examination JAMA 292 2004 1317
36. M. Kriege C.T. Brekelmans C. Boetes P.E. Besnard H.M. Zonderland I.M. Obdeijn et al. Magnetic Resonance Imaging Screening Study Group. Efficacy of MRI and mammography for breast-cancer screening in women with a familial or genetic predisposition N Engl J Med 351 2004 427-437
37. F. Podo F. Sardanelli et al. The Italian multi-centre project on evaluation of MRI and other imaging modalities in early detection of breast cancer in subjects at high genetic risk J Exp Clin Cancer Res 21 2002 115-124
38. M. Robson E.A. Morris N. Kauff et al. Breast cancer screening utilizing magnetic resonance imaging (MRI) in carriers of BRCA mutations (abstr.) Proc Am Soc Clin Oncol 22 2003 91
39. G. Trecate D. Vergnaghi S. Bergonzi T. De Simone E. Fengoni C. Costa et al. Breast MRI screening in patients with increased familial and/or genetic risk for breast cancer: A preliminary experience Tumori 89 2003 125-131
40. C.K. Kuhl S. Schrading C.C. Leutner N. Morakkabati D. Trog R. Schmutzler et al. Surveillance of "high risk" women with proven or suspected familial (hereditary) breast cancer: First mid-term results of a multi-modality clinical screening trial J Clin Oncol 21 Suppl 2003 238